{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:16:02Z","timestamp":1788336962699,"version":"build-2803163510"},"reference-count":40,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s455515","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T08:05:50Z","timestamp":1720080350000},"page":"2773-2783","source":"Crossref","is-referenced-by-count":3,"title":["Real-World Use and Treatment Outcomes of Ceftaroline Fosamil in Patients with Complicated Skin and Soft Tissue Infection: A Multinational Retrospective Study"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Tristan","family":"Ferry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Gogos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2285-9970","authenticated-orcid":true,"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeeha","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kantecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schweikert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"iii35","DOI":"10.1093\/jac\/dkq302","volume":"65","author":"Dryden","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3201\/eid1509.081228","volume":"15","author":"Edelsberg","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijantimicag.2016.04.023","volume":"48","author":"Nathwani","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"101539","DOI":"10.1016\/j.bjid.2021.101539","volume":"25","author":"Leme","year":"2021","journal-title":"Braz J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MJT.0b013e31821109ec","volume":"20","author":"Culos","year":"2013","journal-title":"Am J Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13017-018-0219-9","volume":"13","author":"Sartelli","year":"2018","journal-title":"World J Emerg Surg"},{"key":"ref8","first-page":"21","volume":"31","author":"Martin","year":"2010","journal-title":"Clin Biochem Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jgar.2024.02.002","volume":"37","author":"Keikha","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1093\/jac\/dkaa221","volume":"75","author":"Castro","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/mdr.2014.0190","volume":"21","author":"Di Gregorio","year":"2015","journal-title":"Microb Drug Resist"},{"key":"ref13","unstructured":"Allergan. Prescribing information: TEFLARO\u2122 (ceftaroline fosamil) injection for intravenous (IV) use; 2021. Available from: https:\/\/www.allergan.com\/assets\/pdf\/teflaro_pi. Accessed March 15, 2023."},{"key":"ref14","unstructured":"Pfizer. Summary of product characteristics: Zinforo 600 mg powder for concentrate for solution for infusion; 2024. https:\/\/www.ema.europa.eu\/documents\/product-information\/zinforo-epar-product-information_en.pdf. Accessed June 21, 2024."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1086\/657313","volume":"51","author":"File","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"iii19","DOI":"10.1093\/jac\/dkr096","volume":"66","author":"File","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"iii33","DOI":"10.1093\/jac\/dkr097","volume":"66","author":"Low","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1179\/1973947814Y.0000000184","volume":"26","author":"Ramani","year":"2014","journal-title":"J Chemother"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(14)71018-7","volume":"15","author":"Zhong","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ijantimicag.2019.01.016","volume":"53","author":"Corey","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"iv41","DOI":"10.1093\/jac\/dkq254","volume":"65","author":"Corey","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"iv53","DOI":"10.1093\/jac\/dkq255","volume":"65","author":"Wilcox","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1093\/jac\/dkw333","volume":"71","author":"Dryden","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"115292","DOI":"10.1016\/j.diagmicrobio.2020.115292","volume":"99","author":"Cristinacce","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1469-0691.12463","volume":"20","author":"Bassetti","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"106184","DOI":"10.1016\/j.ijantimicag.2020.106184","volume":"56","author":"Bassetti","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1016\/j.jval.2018.09.1382","volume":"21","author":"Soriano","year":"2018","journal-title":"Value Health"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.2147\/IDR.S172366","volume":"11","author":"Leong","year":"2018","journal-title":"Infect Drug Resist"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1179\/1973947813Y.0000000144","volume":"25","author":"Santos","year":"2013","journal-title":"J Chemother"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1086\/655827","volume":"51","author":"Corey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2146\/ajhp120438","volume":"70","author":"Huang","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2217\/cer-2015-0024","volume":"5","author":"Karve","year":"2016","journal-title":"J Comp Eff Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e01007","DOI":"10.1128\/AAC.01007-19","volume":"63","author":"Trinh","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"E377","DOI":"10.1111\/1469-0691.12235","volume":"19","author":"Garau","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1086\/519470","volume":"45","author":"Kollef","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/2047-783X-15-12-554","volume":"15","author":"Eckmann","year":"2010","journal-title":"Eur J Med Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00228-024-03652-2","volume":"80","author":"Xu","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cmi.2017.06.010","volume":"23","author":"Abbas","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijantimicag.2017.05.006","volume":"50","author":"David","year":"2017","journal-title":"Int J Antimicrob Agents"}],"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=100524","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=100524","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T08:05:55Z","timestamp":1720080355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/real-world-use-and-treatment-outcomes-of-ceftaroline-fosamil-in-patien-peer-reviewed-fulltext-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2147\/idr.s455515","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}